HChyN fzx bRd

Research highlights

James Ford, DO

James Ford, DO

The UNMC College of Medicine received grant and funding awards representing approximately $750,000 in new funding in December.

James McClay, MD, emergency medicine, received grants of: $285,304 from West Virginia University for the West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research N3C Initiative; $5,000 from the University of Kansas Medical Center Research Institute to study the effect of ACA Medicaid expansion on diabetes: Diagnosis, treatment, patient compliance and health outcomes; and $3,500 from the University of Kansas Medical Center Research Institute for collaborative research on privacy-preserving federated transfer learning for early acute kidney injury risk prediction.

Matthew Van Hook, PhD, ophthalmology and visual sciences, received a grant of $150,000 from Research to Prevent Blindness to study microglia and the loss of retinal ganglion cell outputs in the brain during glaucoma.

James Ford, DO, pediatrics-oncology/hematology, received a grant of $56,676 from Boston Children’s Hospital for a study of eltrombopag vs. standard first-line management for newly diagnosed immune thrombocytopenia (ITP) in children.

Russell McCulloh, MD, pediatrics-hospital medicine, received a grant of $24,948 from the University of Arkansas for Medical Sciences for the Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network.

Sidharth Mahapatra, MD, PhD, pediatrics-critical care, received a grant of $12,000 from the University of Pennsylvania for the Prone and Oscillation Pediatric Clinical Trial.

Donald Coulter, MD, pediatrics-oncology/hematology, received a grant of $7,200 from Children’s Hospital of Pennsylvania for a trial for patients with de novo AML comparing standard therapy including gemtuzumab (GO) to CPX-351 with GO, and the addition of the FLT3 inhibitor gilteritinib for patients with FLT3 mutations.

Industry-sponsored grants and contracts:

The following industry-sponsored contracts and foundation grants were received.

Diana Florescu, MD, internal medicine-infectious diseases, received funding for a study to evaluate the efficacy and safety of anti-spike SARS-CoV-2 monoclonal antibodies as preexposure phrophylaxis to prevent COVID-19 in immunocompromised participants.

Michele Aizenberg, MD, neurosurgery, received funding for the Glioma Connectome Project.